...
首页> 外文期刊>Respirology : >Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia
【24h】

Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia

机译:与单独使用噻托溴铵相比,在噻托溴铵中联合布地奈德/福莫特罗治疗重度或非常重度COPD的疗效和耐受性:东亚一项随机,多中心研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objectiveTriple combination therapy with tiotropium plus budesonide/formoterol has improved lung function and reduced exacerbation risk in patients with chronic obstructive pulmonary disease (COPD) in Western countries, but no such data exist for East Asian patients. This study aimed to evaluate the efficacy and tolerability of adding budesonide/formoterol to tiotropium compared with tiotropium alone in East Asian patients with severe/very severe COPD.
机译:背景与目的噻托溴铵联合布地奈德/福莫特罗三联疗法在西方国家的慢性阻塞性肺疾病(COPD)患者中改善了肺功能并降低了加重风险,但东亚患者尚无此类数据。这项研究旨在评估在重度/非常重度COPD的东亚患者中,与单独使用噻托溴铵相比,向噻托溴铵中添加布地奈德/福莫特罗的疗效和耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号